NCT01004315View on ClinicalTrials.gov

A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

PHASE3CompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

Not specified

Conditions
Overactive Bladder
Interventions
DRUG

KUC-7483

DRUG

Placebo

DRUG

Tolterodine

Trial Locations (1)

Unknown

Japan, Hokkaido,Tohoku,Kanto,Chubu,Kansai,Shikoku,Kyushu

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT01004315 - A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder | Biotech Hunter | Biotech Hunter